Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation.
There is no firm evidence that patients with breakthrough cancer pain respond better to fentanyl effervescent buccal than to the "lollipop" formulation.